Search Within

Michael Buege

Formats
  1. Journal Article (7)
  2. Meeting Abstract (7)
  3. Review (2)
  4. Research Letter (1)
Groups
  1. Center for Hematologic Malignancies (13)
  2. Department of Medicine (13)
  3. Hematologic Malignancies, Division of (13)
  4. Lymphoma (13)
  5. Clinical Pharmacy Specialists (7)
  6. Epidemiology and Biostatistics (7)

More Groups

People
  1. Terry Pak (8)
  2. Phuong Dao (7)
  3. Andrea Levoir (6)
  4. Anita Kumar (6)
  5. Tim Peterson (6)
  6. Connie Batlevi (4)

More People

Years
  1. 2023 (5)
  2. 2022 (2)
  3. 2021 (5)
  4. 2020 (4)
  5. 2019 (1)
Publications
  1. Blood (6)
  2. Annals of Pharmacotherapy (2)
  3. Blood Advances (2)
  4. Hematological Oncology (2)
  5. Cancer Treatment and Research Communications (1)
  6. Clinical Lymphoma, Myeloma and Leukemia (1)

More Publications

Publishers
  1. American Society of Hematology (8)
  2. Elsevier Inc. (2)
  3. Sage Publications (2)
  4. Wiley Blackwell (2)
  5. John Wiley & Sons (1)
  6. Sage Publications Ltd. (1)

More Publishers

Results (17)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Time to second line Bruton tyrosine kinase therapy and age at its initiation are strongly associated with subsequent overall survival in patients with first relapse of mantle cell lymphoma
    Meeting Abstract

    Villa, D.; Jiang, A.; Crosbie, N.; Rule, S.; McCulloch, R.; Visco, C.; Buege, M. J.; Kumar, A.; Bond, D.; Paludo, J.; more...
    Hematological Oncology (2021)

    Fulltext@MSK | Save
  • Outpatient clinical pharmacy practice in the face of COVID-19 at a cancer center in New York City
    Journal Article

    Yerram, P.; Thackray, J.; Modelevsky, L. R.; Land, J. D.; Reiss, S. N.; Spatz, K. H.; Levoir, A. C.; Pak, T. K.; Dao, P. H.; Buege, M. J.; more...
    Journal of Oncology Pharmacy Practice (2021)

    Fulltext@MSK | Save
  • Outcomes of patients with relapsed mantle cell lymphoma treated with venetoclax: A multicenter retrospective analysis
    Meeting Abstract

    Sawalha, Y.; Goyal, S.; Switchenko, J. M.; Romancik, J. T.; Kamdar, M.; Greenwell, I. B.; Hess, B. T.; Isaac, K.; Portell, C. A.; Garcia, A. V. M.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • IVAC +/- R for relapsed or refractory B-cell non-Hodgkin lymphomas: Real-world experience in the modern era
    Meeting Abstract

    Buege, M. J.; Dao, P. H.; Drill, E.; LeVoir, A. C.; Pak, T.; Peterson, T. J.; Straus, D. J.
    Blood (2020)

    Fulltext@MSK | Save
  • Management of mantle cell lymphoma in the era of novel oral agents
    Review

    Buege, M. J.; Kumar, A.; Dixon, B. N.; Tang, L. A.; Pak, T.; Orozco, J.; Peterson, T. J.; Maples, K. T.
    Annals of Pharmacotherapy (2020)

    Fulltext@MSK | Save
  • Selinexor: A first-in-class nuclear export inhibitor for management of multiply relapsed multiple myeloma
    Review

    Peterson, T. J.; Orozco, J.; Buege, M.
    Annals of Pharmacotherapy (2020)

    Fulltext@MSK | Save
  • Corrected calcium versus ionized calcium measurements for identifying hypercalcemia in patients with multiple myeloma
    Journal Article

    Buege, M. J.; Do, B.; Lee, H. C.; Weber, D. M.; Horowitz, S. B.; Feng, L.; Qing, Y.; Shank, B. R.
    Cancer Treatment and Research Communications (2019)

    Fulltext@MSK | Save